Inc. CVDI develops, manufactures and markets rapid turnaround diagnostics to assess blood clot formation and dissolution. CVDI is also establishing itself in the emerging field of theranostics, or rapid near-patient testing, in which the diagnostic results may influence treatment decisions. Current tests and tests under development are used in the treatment of angina, heart attack, stroke, deep vein thrombosis and pulmonary and arterial emboli.
Revenues reflect the increase in analyzer sales.
Higher losses reflect the inclusion of preferred dividends. VP of Sales, Marketing and Bus. Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide .